People Briefs: St. Jude Medical, JenaValve Technology, Staar Surgical, ElectroCore
This article was originally published in The Gray Sheet
Executive Summary
St. Jude Medical names Zimmer Biomet CEO David Dvorak to board of directors, JenaValve appoints CFO, electroCore taps chief medical officer, and Staar Surgical names VP, research & development.
You may also be interested in...
Zimmer, Biomet Sell Off Some U.S. Assets As They Finalize A $14 Bil. Merger
Zimmer Biomet is now the second-largest orthopedic device maker behind Johnson & Johnson now that the merger between the two firms is complete. The companies divested some U.S. knee, elbow and bone cement assets in conjunction with finalized the deal after having sold of some European assets earlier in the year.
US FDA’s June User Fee Calendar Starts Out Steady, But A Crescendo Of Decisions Will Start Mid-Month
Two gene therapies and two novel inhibitors of JAK kinases are among the upcoming goal dates from the Pink Sheet’s US FDA Performance Tracker.
Supplemental Filings: FDA Expands In-Person Meeting Eligibility Again; Marks Suggests Sponsors Invite Foreign Regulators To FDA Meetings
More formal meetings are available for in-person sessions with the US FDA. Also, CBER Director Peter Marks offers advice for conducting meetings, from how to do hybrid right to how to include patient groups and foreign regulators.